- Investing Ideas
- French Biotech Breakthroughs
French Biotech Breakthroughs
Results
2
1 new
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
2 companies
DBV Technologies
Market Cap: €941.6m
A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.
DBV
€3.18
7D
-5.1%
1Y
112.7%
ABIVAX Société Anonyme
Market Cap: €8.4b
A clinical-stage biotechnology company, develops therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.
New
ABVX
€105.90
7D
6.9%
1Y
1,992.9%